Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2023-05-02 Capital/Financing Update
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
LCT Announces Shortfall Completion Notice 1 page 99
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Living Cell Technologies Limited regarding the completion of an entitlement offer shortfall, which is a capital raising activity. It mentions allocation of funds and references a prior quarterly report but does not contain any financial statements or detailed financial data itself. The document length is only 1742 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2023-05-02 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 159.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'March Quarterly Activities Report and Appendix 4C Cash Flow Statement' and is an ASX announcement. It provides detailed quarterly operational updates, cash flow statements, and financing activities for the quarter ended 31 March 2023. The presence of an Appendix 4C cash flow report, which is a standard quarterly report for entities listed on the ASX, confirms this is a quarterly report. The document contains substantive financial data including cash flows from operating, investing, and financing activities, as well as cash balances and funding estimates. It is not merely an announcement of a report but includes the actual financial data and analysis for the quarter. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-04-27 English
Change of Director's Interest Notice 2 pages 198.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the change, and dates. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. The document is concise and focused solely on director share transactions, with no financial statements or broader company performance data. Therefore, it fits the 'Director's Dealing' category (DIRS).
2023-04-26 English
Change of Director's Interest Notice 2 pages 195.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares/options acquired and disposed, dates, and nature of the change. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is short and focused solely on director share transactions, with no financial statements or other report content. Therefore, it fits the 'Director's Dealing' category (DIRS).
2023-04-26 English
Application for quotation of securities - LCT 6 pages 27.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX by Living Cell Technologies Limited. It details the number and type of securities to be quoted, issue dates, distribution schedules, and issued capital following quotation. The document references Appendix 3B filings and is focused on the listing and quotation of new securities rather than financial results or management information. This fits the category of announcements related to share issues or capital changes, specifically the quotation of new securities on the exchange. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement but a detailed application for quotation, supporting a high confidence score.
2023-04-20 English
Notification regarding unquoted securities - LCT 5 pages 26.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities by Living Cell Technologies Limited. It includes specifics such as the number of securities issued, issue dates, and references to previous announcements (Appendix 3B). The content focuses on the issuance of securities and capital changes rather than financial results, management changes, or regulatory certifications. The document length is about 5,094 characters, which is sufficient to contain substantive information about the securities issuance. Therefore, this document fits the category of a Share Issue/Capital Change announcement.
2023-04-20 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.